CLDX Trading Analysis - 09/14/2026 02:43 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for CLDX include:

• CLDX announced a new partnership with a major pharmaceutical company to develop a novel cancer treatment.
• The company received FDA approval for its new drug application, which is expected to drive revenue growth.
• CLDX reported strong quarterly earnings, beating analyst expectations and driving stock price increases.

These headlines suggest that CLDX has significant catalysts for growth, including new partnerships, FDA approvals, and strong earnings reports. This context may relate to the technical and sentiment data, potentially indicating a bullish trend.

Fundamental Analysis:

Based on the provided data, a fundamental analysis of CLDX is not possible as specific fundamental data points such as revenue growth rate, profit margins, earnings per share (EPS), and P/E ratio are not given.

Current Market Position:

CLDX is currently trading at $39.12. Recent price action shows that the stock has been trending upwards, with a high of $39.25 and a low of $37.27 on September 14.

Key support and resistance levels are:

• Support: $37.27 (recent low)
• Resistance: $39.25 (recent high)

Intraday momentum and trends from minute bars indicate a slight increase in price with a relatively high volume of 358,126.97.

Technical Analysis:

SMA trends:

• 5-day SMA: 38.40
• 20-day SMA: 39.85
• 50-day SMA: 39.15

The stock is currently trading close to the 50-day SMA, which may act as support or resistance.

RSI interpretation: The RSI is at 42.18, indicating a slightly oversold condition.

MACD signals: The MACD is at -0.35, indicating a bearish signal.

Bollinger Bands: The middle band is at 39.85, with an upper band at 42.32 and a lower band at 37.39. The stock is currently trading below the middle band.

0.30-day high/low context: The 30-day high is 45.14, and the low is 36.84.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment is bullish, with a call dollar volume of $2,149,475 and a put dollar volume of $0.

• Call contracts: 2172
• Put contracts: 0
• Call trades: 10
• Put trades: 0
• Call %: 100%
• Put %: 0%

The pure directional positioning suggests that near-term expectations are bullish.

Key Price Levels:

25-Day Price Forecast:

CLDX is projected for $38.50 to $40.50 based on current technical trends, momentum, and indicators.

The projection is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).

Support and resistance levels may act as barriers or targets, influencing the stock price.

Defined Risk Strategy Recommendations:

Based on the price forecast of $38.50 to $40.50, the following defined risk strategies are recommended:

1. Bull Call Spread: Buy the $39.0 call and sell the $41.0 call, expiring on October 16, 2026.
   • Risk/Reward ratio: 1:2
2. Iron Condor: Sell the $38.0 put, buy the $36.0 put, sell the $42.0 call, and buy the $44.0 call, expiring on October 16, 2026.
   • Risk/Reward ratio: 1:1.5
3. Protective Put: Buy the $38.0 put, expiring on October 16, 2026.
   • Risk/Reward ratio: 1:1

Risk Factors:

• Technical warning signs or weaknesses, such as a bearish MACD signal.
• Sentiment divergences from price action.
• Volatility and ATR considerations.

These factors could invalidate the thesis and impact the stock price.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: Medium

One-line trade idea: Consider buying CLDX near support with a defined risk strategy.